These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23177511)

  • 21. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient.
    Sharma P; Kumar A
    Saudi J Gastroenterol; 2012; 18(5):316-21. PubMed ID: 23006459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores.
    Prohic D; Mesihovic R; Vanis N; Puhalovic A
    Med Arch; 2016 Feb; 70(1):48-52. PubMed ID: 26980932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    Ripoll C; Groszmann RJ; Garcia-Tsao G; Bosch J; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS;
    J Hepatol; 2009 May; 50(5):923-8. PubMed ID: 19303163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of Hepatic Venous Pressure Gradient Level With Clinical and Endoscopic Parameters in Decompensated Chronic Liver Disease.
    Sathawane A; Khobragade H; Pal S
    Cureus; 2023 Dec; 15(12):e51154. PubMed ID: 38283456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive Value of Hepatic Venous Pressure Gradient for Graft Hemodynamics in Living Donor Liver Transplantation.
    Matsushima H; Fujiki M; Sasaki K; Rotroff DM; Sands M; Bayona Molano MDP; Aucejo F; Diago Uso T; Eghtesad B; Miller C; Quintini C; Hashimoto K
    Liver Transpl; 2019 Jul; 25(7):1034-1042. PubMed ID: 30980599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY; Suk KT; Jeong SW; Ryu T; Kim DJ; Baik SK; Sohn JH; Jeong WK; Choi E; Jang JY; Kim MY
    J Korean Med Sci; 2019 Aug; 34(33):e223. PubMed ID: 31436052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
    Dittrich S; Yordi LM; de Mattos AA
    Hepatogastroenterology; 2001; 48(37):166-8. PubMed ID: 11268957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
    Ripoll C; Lastra P; Rincón D; Catalina V; Bañares R
    Scand J Gastroenterol; 2012 Feb; 47(2):204-11. PubMed ID: 22242615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.
    Caraceni P; Tufoni M; Zaccherini G; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Simone L; Svegliati-Baroni G; Fagiuoli S; Laffi G; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Gasbarrini A; De Marco R; Piano S; Nardelli S; Elia C; Roncadori A; Baldassarre M; Bernardi M;
    J Hepatol; 2021 Feb; 74(2):340-349. PubMed ID: 32853747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis.
    Sersté T; Bourgeois N; Lebrec D; Evrard S; Devière J; Le Moine O
    Acta Gastroenterol Belg; 2006; 69(4):355-60. PubMed ID: 17343075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding.
    La Mura V; Garcia-Guix M; Berzigotti A; Abraldes JG; García-Pagán JC; Villanueva C; Bosch J
    Hepatology; 2020 Oct; 72(4):1353-1365. PubMed ID: 31960441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perendoscopic variceal pressure measurement: a reliable estimation of portal pressure in patients with cirrhosis?
    Spahr L; Giostra E; Morard I; Mentha G; Hadengue A
    Gastroenterol Clin Biol; 2006; 30(8-9):1012-8. PubMed ID: 17075452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.
    Schwabl P; Bucsics T; Soucek K; Mandorfer M; Bota S; Blacky A; Hirschl AM; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Sep; 35(9):2121-8. PubMed ID: 25644943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical ascites defines an intermediate stage between compensated and decompensated cirrhosis.
    Zipprich A; Seufferlein T; Dollinger MM
    Z Gastroenterol; 2012 Sep; 50(9):996-1001. PubMed ID: 22965629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.